Lecturer/Family Physician, Department of Family Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka.
Palliative Care Consultant, Bethesda Health Care, Claremont, Australia.
Int J Palliat Nurs. 2021 Sep 2;27(7):362-366. doi: 10.12968/ijpn.2021.27.7.362.
Nausea and vomiting are two interrelated distressing symptoms experienced by patients with malignancies. They are multifactorial in aetiology.
A middle-aged woman diagnosed with bilateral ovarian malignancy had undergone chemotherapy and was suffering nausea and vomiting, and was responding to basic therapeutic measures.
She was resistant to treatment with metoclopramide that was commenced by the oncology team, as for any patient with nausea and vomiting. This report examines a 'mechanistic' approach to nausea management and life-style modifications.
Within 2 days of the evidence-based revision of her management plan, the patient expressed that she had experienced a significant symptomatic relief and an improvement in her general wellbeing.
The early identification of the most probable causative factors of nausea and vomiting in patients with advanced malignancies will lead to significant improvements in their quality of life and save time and resources.
恶心和呕吐是恶性肿瘤患者经历的两种相互关联的痛苦症状。它们在病因上具有多因素性。
一名中年妇女被诊断出患有双侧卵巢恶性肿瘤，已接受化疗，现正遭受恶心和呕吐的困扰，并对基本治疗措施有反应。
她对肿瘤团队开始使用的甲氧氯普胺治疗产生了耐药性，就像任何患有恶心和呕吐的患者一样。本报告探讨了一种“机制”方法来管理恶心和改变生活方式。
在对她的管理计划进行基于证据的修订后的 2 天内，患者表示她的症状明显缓解，整体健康状况得到改善。
早期识别晚期恶性肿瘤患者恶心和呕吐的最可能原因，将显著提高他们的生活质量，并节省时间和资源。
